SCHEMBL6841553

SCHEMBL6841553

COc1ccc(C(c2ccccc2)(c2ccc(OC)cc2)C(O)[C@H]2O[C@@H](n3cnc4c(=O)[nH]c(NC(=O)C(C)C)nc43)C[C]2O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.46
TYMP P19971 2/20 0.40
TAS1R3 Q7RTX0 1/20 0.38
TAS1R1 Q7RTX1 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.36
NPC1 O15118 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
RAB9A P51151 1/20 0.36
PDE9A O76083 4/20 0.35
TAAR1 Q96RJ0 2/20 0.35
HPGD P15428 1/20 0.34
PAX3 P23760 1/20 0.34
FOXO1 Q12778 1/20 0.34
PDE5A O76074 2/20 0.33
PDE4A P27815 2/20 0.33
PDE1B Q01064 2/20 0.33
PDE4B Q07343 2/20 0.33
PDE4C Q08493 2/20 0.33
PDE4D Q08499 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7534659 0.86 KDM4E (0.49) KDM4ETYMPTAS1R3TAS1R1SMN1; SMN2
SCHEMBL2113125 0.86 KDM4E (0.49) KDM4ETYMPTAS1R3TAS1R1SMN1; SMN2
SCHEMBL441421 0.84 TYMP (0.48) KDM4ETYMPTAS1R3TAS1R1TAAR1
SCHEMBL4553693 0.82 KDM4E (0.51) KDM4ETYMPTAS1R3TAS1R1SMN1; SMN2
SCHEMBL9116775 0.82 KDM4E (0.42) KDM4ETYMPTAS1R3TAS1R1SMN1; SMN2
SCHEMBL5963306 0.81 TYMP (0.44) KDM4ETYMPTAS1R3TAS1R1PDE9A
SCHEMBL9294603 0.81 TYMP (0.44) KDM4ETYMPTAS1R3TAS1R1PDE9A
SCHEMBL11281236 0.81 KDM4E (0.46) KDM4ETYMPTAS1R3TAS1R1SMN1; SMN2
SCHEMBL21065504 0.80 TYMP (0.47) KDM4ETYMPTAS1R3TAS1R1SMN1; SMN2
SCHEMBL6839735 0.80 ADORA2A (0.43) TYMP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6756496-B1 SUCH AS TRIETHYLAMMONIUM-5'-DIMETHOXYTRITYL-3'-THYMIDINE-HYDROGEN PHOSPHONONDITHIOATE FOR USE AS ANTIVIRAL AND ANTICANCER AGENTS ISIS PHARMACEUTICALS, INC. 2004-06-29 US claimed
EP-0360609-A2 Novel hydrogen phosphonodithioate compositions GILEAD SCIENCES, INC. (US) 1990-03-28 EP claimed